Clinical Trial Update: Efficacy on Height in SGA Children Treated With Growth Hormone [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating growth hormone therapy (somatropin) for increasing height in children who were small for gestational age.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Small For Gestational Age

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Foetal Growth Problem, Small for Gestational Age | Phase 3 | Status: COMPLETED